InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Browse the detailed record of transactions filed by Miller Andrew Craig, Dirigeant. Officer active across 1 companies, notably Karuna Therapeutics, Inc.. Cumulatively, 12 filings have been recorded. Total volume traded: €460k. The latest transaction was disclosed on 2 November 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is free.
Declarations12 total
€66,70926,500 shares@ €2.517314.3% of flow
Common Stock
SEC:0001593968-21-002357·
€66,70926,500 shares@ €2.51737.2% of flow
Common Stock
SEC:0001593968-21-002357:0·
€71,697700 shares@ €102.423615.4% of flow
Common Stock
SEC:0001593968-21-002238·
€71,697700 shares@ €102.42367.7% of flow
Common Stock
SEC:0001593968-21-002238:0·
€158,2761,590 shares@ €99.544733.9% of flow
Common Stock
SEC:0001593968-21-002085·
€158,2761,590 shares@ €99.544717.0% of flow
Common Stock
SEC:0001593968-21-002085:0·
€30,98512,500 shares@ €2.47886.6% of flow
Common Stock
SEC:0001593968-21-001993·
€30,98512,500 shares@ €2.47883.3% of flow
Common Stock
SEC:0001593968-21-001993:0·
€100,77113,333 shares@ €7.55821.6% of flow
Common Stock
SEC:0001593968-21-001617·
€100,77113,333 shares@ €7.55810.8% of flow
Common Stock
SEC:0001593968-21-001617:0·
€37,8885,000 shares@ €7.57778.1% of flow
Common Stock
SEC:0001593968-21-001293·
€37,8885,000 shares@ €7.57774.1% of flow
Common Stock
SEC:0001593968-21-001293:0·
12 of 12 declarations
About Miller Andrew Craig
Andrew Craig Miller is the Chief Operating Officer at Karuna Therapeutics, Inc. He is responsible for managing the company's operations and strategy. Andrew Craig Miller plays a key role in improving operational processes and product development. His expertise in business management and operations is essential to ensure that Karuna Therapeutics, Inc. meets its growth and innovation objectives.
